32 results
Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

D2.262 - Measurement of tryptasemia in a university hospital: prescribing reality versus recommendations

Thumbnail

D2.263 - Anaphylaxis induced by goat’s and sheep’s milk: an allergen that we should keep under surveillance

Thumbnail

D2.264 - Food-induced Anaphylaxis: Characterization and Trends of a Four-year Single-center Survey

Thumbnail

D2.265 - Allergy to peas and lentils: data from the Allergy-Vigilance Network

Thumbnail

D2.266 - Four-Year Analysis of the Incidence and Clinical Features of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit, Universitary Hospital Cruz Roja

Thumbnail

D2.267 - MiRNA-29a is downregulated in food anaphylaxis and involved in the endothelial glycocalyx stability

Thumbnail

D2.269 - Diagnostic challenges in evaluating diagnosis of mast cell disorder in a patient with severe allergy to hymenoptera venom

Thumbnail

D2.270 - Roadmap of anaphylaxis registries across the world

Thumbnail

D2.271 - The non-mandatory food allergens that we should not sweep under the rug: data from the Allergy-Vigilance Network

Thumbnail

D2.272 - Anaphylaxis caused by Psyllium